E-BOOK
4
E-BOOK
5
TREND #1
COMPLEX STUDY PROTOCOLS
Early-phase clinical trials in oncology are becoming increasingly complex. Study protocols encompass different cohorts and scenarios, combined phases, multiple elaborate assessments, extensive sampling and interim analyses. The challenge lies in the fact that study sites often lack the resources and expertise required to execute these complex protocols.
However, this challenge also presents an opportunity to improve the process. By providing intuitive instructions and meticulously designed visit kits, it’s possible to simplify sample collection, handling and processing procedures at study sites. Additionally, thoroughly training study site personnel can empower them to navigate these multifaceted protocols more adeptly.
Rise in cancer-targeting drug development amplifies early-phase oncology trials
PROTOCOL ADAPTATIONS
Early oncology trials are known for their volatility, with protocols often adapting based on new outcomes or patient well-being considerations. Flexibility and adaptability are key. It’s essential to establish clear processes for dealing with protocol amendments to ensure efficient adaptation. Moreover, maintaining transparency in cost structures is crucial to avoid unexpected financial burdens during protocol changes.
Early oncology trials are dynamic, often requiring protocol adaptations. Clear processes and cost transparency are essential for efficient and flexible trial management.
source: statista.com
TREND #2
The influx of biomarkers in oncology trials
source: statista.com
Made with FlippingBook - PDF hosting